Hysolv Animal Health have launched a one-shot vaccine against oedema disease in piglets and is available in the UK and the Republic of Ireland. A single 1ml dose is injected and immunity lasts for the whole rearing and finishing period.
Oedema is a lethal infectious disease seen in pig production. It primarily occurs in piglets during the first weeks after weaning. It causes serious losses to the pig industry due to a high mortality rate among infected pigs.
The vaccine* induces a high level of immunity against shiga toxin, produced by the E coli bacteria which cause oedema. It has proved highly successful in Germany where it was developed by IDT Biologika. In a comparative study involving 319 pigs no mortality was recorded among the vaccinated group compared with 11.4% in the unvaccinated control group.
Preventative measures in a cost-effective way
"Vaccines* like this can significantly reduce the use of antibiotics in piglet rearing, acting as a preventative measure in a welfare-focussed and cost-effective way. We are advising producers to work closely with their vets on this." commented Hysolv director Richard Brealey.
German calculation showed a reduction in margin of €83 (£74) per sow or €41,000 (£32,500) for a 500-sow herd. UK farmers will be able to carry out at DIY calculation of their ROI online using their smartphones of by visiting the shiga toxin website.
To comment, login here
Or register to be able to comment.